Through computational structural analysis and ACMG-based variant interpretation, we characterized the mutation's potential impact on CK2β conformation within the topoisomerase II interaction domain, expanding the phenotype spectrum of CSNK2B-related disorders, and the first reported association between POBINDS and Jeavons syndrome. Here, CSNK2B is linked to epilepsy with eyelid myoclonia.